Home > PE Ratio > WINDLAS BIOTECH

WINDLAS BIOTECH
PE (Price/Earnings) Ratio

The Current P/E Ratio of WINDLAS BIOTECH is 36.30.

Share Price ₹1,063.5Dec 11,2024
Market Cap ₹2,222.6 Cr
Earnings-TTM₹61.2 CrTTM-Consolidated Results
Price/Earnings36.30xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for WINDLAS BIOTECH
Please provide your vote to see the results
WINDLAS BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of WINDLAS BIOTECH

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of WINDLAS BIOTECH is calculated as :

Current Market Cap [ ₹2,222.6 Cr] as on Dec 11,2024

(/) Earnings [ ₹61.2 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 36.30x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for WINDLAS BIOTECH , the investors are currently willing to pay 36.30 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of WINDLAS BIOTECH !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of WINDLAS BIOTECH over the last five years.

Historical PE (Price/Earnings) ratio chart of WINDLAS BIOTECH


PE Ratio Performance Analysis for WINDLAS BIOTECH

- WINDLAS BIOTECH 's latest p/e ratio is 36.30x.

- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.28x.

- WINDLAS BIOTECH 's operated at median p/e ratio of 11.06x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2024 at 18.31x.

- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.


How does WINDLAS BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
WINDLAS BIOTECH 61.2336.302,222.6
SUN PHARMACEUTICAL INDUSTRIES LTD11,136.5039.10435,407.0
CIPLA LTD4,485.2226.18117,443.0
DR REDDYS LABORATORIES LTD5,406.8019.11103,338.0
ZYDUS LIFESCIENCES LTD4,298.9023.0999,244.9
DIVIS LABORATORIES LTD1,836.0085.78157,489.0
MANKIND PHARMA LTD2,124.8649.46105,098.0
TORRENT PHARMACEUTICALS LTD1,802.0063.38114,202.0
LUPIN LTD2,651.9436.9798,055.1
AUROBINDO PHARMA LTD3,598.8319.7871,188.9
ABBOTT INDIA LTD1,284.6647.7561,336.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs WINDLAS BIOTECH 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.11x
Max industry PE 85.78x
Median industry PE 36.97x
Average industry PE 40.63x



You may also like the below Video Courses